Literature DB >> 17949548

The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behçet's disease.

G Mumcu1, N Inanc, S Yavuz, H Direskeneli.   

Abstract

Behçet's disease (BD) is a multisystemic disorder characterized by oral, genital ulcers and involvement of the cutaneous (erythema nodosum, pustular vasculitis), ocular (anterior or posterior uveitis), musculoskeletal, vascular (both arterial and venous vasculitis), gastrointestinal and central nervous (meningoencephalitis) systems. It has an unpredictable clinical spectrum from mild mucocutaneous manifestations to severe ocular, vascular or neurological disability. In this review, the aetiology, clinical presentations and treatment modalities of BD are evaluated in the context of microbial factors within the existing literature. The relationships between microbial agents (streptococcia and herpes simplex virus), microbial antigens [heat shock proteins (HSP), lipoteichoic acid (LTA)] and immune mechanisms such as innate and adaptive responses against microorganisms are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17949548

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  26 in total

1.  Immune and inflammatory gene expressions are different in Behçet's disease compared to those in Familial Mediterranean Fever.

Authors:  Filiz Türe Özdemir; Emel Ekşioğlu Demiralp; Sibel Z Aydın; Pamir Atagündüz; Tülin Ergun; Haner Direskeneli
Journal:  Eur J Rheumatol       Date:  2016-12-01

2.  Evaluation of asymptomatic venous disease by venous Doppler ultrasonography in patients with Behcet's disease without overt thrombosis.

Authors:  Fatma Alibaz-Oner; Emrah Karatay; Ihsan Nuri Akpinar; Tulin Ergun; Haner Direskeneli
Journal:  Clin Rheumatol       Date:  2013-09-07       Impact factor: 2.980

Review 3.  Behçet's disease: recent advances in early diagnosis and effective treatment.

Authors:  Kenneth T Calamia; Phaedon G Kaklamanis
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

Review 4.  Behçet syndrome: a contemporary view.

Authors:  Hasan Yazici; Emire Seyahi; Gulen Hatemi; Yusuf Yazici
Journal:  Nat Rev Rheumatol       Date:  2018-01-03       Impact factor: 20.543

Review 5.  An update on the role of epigenetics in systemic vasculitis.

Authors:  Patrick Coit; Haner Direskeneli; Amr H Sawalha
Journal:  Curr Opin Rheumatol       Date:  2018-01       Impact factor: 5.006

Review 6.  Behçet Disease: An Update for Dermatologists.

Authors:  Erkan Alpsoy; Burcin Cansu Bozca; Asli Bilgic
Journal:  Am J Clin Dermatol       Date:  2021-06-01       Impact factor: 7.403

7.  Neutrophil hyperchemotaxis in Behçet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses.

Authors:  Fabricio Souza Neves; Solange Carrasco; Cláudia Goldenstein-Schainberg; Célio Roberto Gonçalves; Suzana Beatriz Veríssimo de Mello
Journal:  Clin Rheumatol       Date:  2009-08-25       Impact factor: 2.980

Review 8.  Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's disease.

Authors:  M Giza; D Koftori; L Chen; P Bowness
Journal:  Clin Exp Immunol       Date:  2017-10-06       Impact factor: 4.330

9.  Unmet need in Behcet's disease: most patients in routine follow-up continue to have oral ulcers.

Authors:  Fatma Alibaz-Oner; Gonca Mumcu; Zeynep Kubilay; Gulsen Ozen; Gulce Celik; Aslı Karadeniz; Meryem Can; Sibel Yilmaz Oner; Nevsun Inanc; Pamir Atagunduz; Tulin Ergun; Haner Direskeneli
Journal:  Clin Rheumatol       Date:  2014-04-16       Impact factor: 2.980

Review 10.  'MHC-I-opathy'-unified concept for spondyloarthritis and Behçet disease.

Authors:  Dennis McGonagle; Sibel Zehra Aydin; Ahmet Gül; Alfred Mahr; Haner Direskeneli
Journal:  Nat Rev Rheumatol       Date:  2015-11-03       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.